Results 111 to 120 of about 1,121 (144)

A 1-km resolution dataset of affordability-constrained accessibility to elderly care facilities in China. [PDF]

Sci Data
Wang X, Xu Q, Wang Y, Wu F.
europepmc   +1 more source

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B. [PDF]

Infect Agent Cancer
Ma Q, Ye J, Luo L, Sun Y, Wang W, Feng S, Liao B, Zhong B.   +7 more
europepmc   +1 more source

Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C. [PDF]

J Gastroenterol Hepatol
Lee YR, Woo HY, Kweon YO, Tak WY, Jang SY, Park JG, Kang MK, Song JE, Jang BK, Lee C, Kim BS, Hwang JS, Chung WJ, Heo J, Heo NY, Park SH, Yoon JS, Jeong J, Kwak SG, Kang Y, Baek YH, Park SY.   +21 more
europepmc   +1 more source

Trajectory Modelling of Prognostic Biomarkers Linked to Liver Cancer Risk: A Systematic Review. [PDF]

Liver Cancer
Aldawsari B, Bonnett LJ, Sudell M, Johnson P, Hughes DM.   +4 more
europepmc   +1 more source

Potential link between tastes preference and digestive system cancer hospitalisations in Fujian Province, China: big data analytics. [PDF]

Public Health Nutr
Rao Z, Huang J, Zhuang Z, Zheng J, Tang X, Wang H, Hu Z, Peng X.   +7 more
europepmc   +1 more source

The association between inflammatory, metabolic, and hepatic fibrosis-related biomarkers and atrial fibrillation in older patients with metabolic dysfunction-associated steatotic liver disease. [PDF]

BMC Geriatr
Zhang S, Liang H, Liu J, Huang Z, Shi X, Zhu Y.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients

Clinical Gastroenterology and Hepatology, 2023
The changes in liver stiffness measurement (LSM) are unreliable to estimate regression of fibrosis during antiviral treatment for chronic hepatitis B (CHB) patients. The age-male-albumin-bilirubin-platelets score (aMAP), as an accurate hepatocellular carcinoma risk score, may reflect the liver fibrosis stage.
Wen-Yue Liu, Xiao-Zhi Jin
exaly   +3 more sources

aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C

Hepatology Research, 2021
AbstractAimsHepatocellular carcinoma (HCC) can still occur in hepatitis C virus (HCV) patients who have achieved a sustained virologic response (SVR), which remains an important clinical issue in the direct‐acting antivirals era. The current study investigated the clinical utility of the aMAP score (consisting of age, male, albumin–bilirubin, and ...
Yuki Yamashita, Satoru Joshita, Ayumi Sugiura   +2 more
exaly   +3 more sources

The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis

Hpb
The aMAP score is a proposed model to predict the development of hepatocellular carcinoma (HCC) among high-risk patients with chronic hepatitis. The role of the aMAP score to predict long-term survival among patients following resection of HCC has not been determined.Patients undergoing resection for HCC between 2000 and 2020 were identified using a ...
Yutaka Endo, Francesca Ratti, Vincent Lam   +2 more
exaly   +3 more sources